Evidence map›Paper›PMID 42272174›Full record

ArticleCurrent drug delivery2026

Corrigendum to: Nanoparticle-Mediated Transcytosis in Tumor Drug Delivery: Mechanisms, Categories, and Novel Applications.

Nakaooh Doaa, Signa Lon Rolande Detorgma, Kaiyun Yang, Rajae Salama, Wenli Zhang

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Current drug delivery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nakaooh DoaaDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, PR China.
Signa Lon Rolande DetorgmaDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, PR China.
Kaiyun YangSchool of Pharmacy, University of Auckland, Private Bag 92019, Auckland, New Zealand.
Rajae SalamaDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, PR China.
Wenli ZhangDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the published article [1], text under heading 5 was inadvertently omitted during the final processing of the manuscript. This error has now been corrected, and the references have been updated. This correction does not affect the scientific content, data interpretation, or conclusions of the article. The original article is available online at: https://www.benthamscience.com/article/143767 The publisher apologizes for any inconvenience caused to the authors and readers. Details of the correction is provided below: Corrected: 5. THE DIFFERENCE BETWEEN AMT, RMT, AND CMT AMT, RMT, and CMT represent distinct transcytosis mechanisms: AMT relies on non-specific electrostatic interactions, RMT depends on specific binding to cellsurface receptors, while CMT utilizes carrier cells (e.g., immune cells) to transport drugs or nanoparticles. The key differences between these mechanisms are summarized in Table 2.

Identifiers

PMID42272174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.